Literature DB >> 22957701

A comprehensive study on long-term injury to nigral dopaminergic neurons following intracerebroventricular injection of lipopolysaccharide in rats.

Yan Zhou1, Yanxin Zhang, Junquan Li, Fengyue Lv, Yongmei Zhao, Deyi Duan, Qunyuan Xu.   

Abstract

Parkinson's disease (PD) is characterized by selective and progressive degeneration of dopaminergic neurons in the substantia nigra (SN). Lipopolysaccharide (LPS) can induce chronic inflammation and has been widely used to study the pathogenesis of PD. In this study, a single intracerebroventricular injection of LPS was used to induce neurotoxic effects on dopaminergic neurons in Sprague-Dawley rats. The long-term neurotoxic effects of LPS were evaluated at different time points. Microglia were activated in the hippocampus and striatum at 4 weeks, and in the SN at 24 weeks. Astrocytes were activated in the hippocampus and nigrostriatal system at 2 and 24 weeks. The expression of brain-derived neurotrophic factor in the SN increased at 4 weeks and decreased after 12 weeks, and tyrosine hydroxylase-positive neurons in the SN were shown to have an atrophic appearance, with cell loss evident after 24 weeks. Phospho-α-synuclein expression, a reflection of parkinsonian pathogenesis, increased at 12 weeks, and peaked at 24 weeks. Abnormal motor behavior appeared at 16 weeks and lasted up to 48 weeks. These results indicate that microglia are activated for several months after a single, low dose injection of LPS, which eventually results in progressive and selective damage to dopaminergic neurons in the SN.
© 2012 The Authors Journal of Neurochemistry © 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22957701     DOI: 10.1111/jnc.12010

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  The prion hypothesis of Parkinson's disease.

Authors:  Yaping Chu; Jeffrey H Kordower
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

2.  Synthesis and biological evaluation of substituted N-[3-(1H-pyrrol-1-yl)methyl]-1,2,5,6-tetrahydropyridin-1-yl]benzamide/benzene sulfonamides as anti-inflammatory agents.

Authors:  Madhavi Gangapuram; Elizabeth Mazzio; Suresh Eyunni; Karam F A Soliman; Kinfe K Redda
Journal:  Arch Pharm (Weinheim)       Date:  2014-03-02       Impact factor: 3.751

Review 3.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

4.  Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation.

Authors:  Serena Becchi; Alberto Buson; Jonathan Foot; Wolfgang Jarolimek; Bernard W Balleine
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

Review 5.  A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets.

Authors:  Chenere P Ramsey; Malú G Tansey
Journal:  Exp Neurol       Date:  2013-05-28       Impact factor: 5.330

Review 6.  Fatting the brain: a brief of recent research.

Authors:  Ghulam Hussain; Florent Schmitt; Jean-Philippe Loeffler; Jose-Luis Gonzalez de Aguilar
Journal:  Front Cell Neurosci       Date:  2013-09-09       Impact factor: 5.505

7.  Alkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide.

Authors:  Huan He; Wei-Wei Guo; Rong-Rong Xu; Xiao-Qing Chen; Nan Zhang; Xia Wu; Xiao-Min Wang
Journal:  BMC Complement Altern Med       Date:  2016-10-24       Impact factor: 3.659

8.  Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators.

Authors:  Hyeon-Sook Suh; Meng-Liang Zhao; Leandra Derico; Namjong Choi; Sunhee C Lee
Journal:  J Neuroinflammation       Date:  2013-03-12       Impact factor: 8.322

Review 9.  Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.

Authors:  Oddvar Myhre; Hans Utkilen; Nur Duale; Gunnar Brunborg; Tim Hofer
Journal:  Oxid Med Cell Longev       Date:  2013-04-17       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.